Incidence of Heterotopic Ossification in Direct Anterior Approach to Total Hip Arthroplasty with use of Aspirin as Thromboembolic Prophylaxis.

Spartan medical research journal Pub Date : 2020-06-08
Paul Knapp, Ross Doehrmann, Sanar Yokhana, Syed Rizvi, Judith Boura, David Knesek
{"title":"Incidence of Heterotopic Ossification in Direct Anterior Approach to Total Hip Arthroplasty with use of Aspirin as Thromboembolic Prophylaxis.","authors":"Paul Knapp, Ross Doehrmann, Sanar Yokhana, Syed Rizvi, Judith Boura, David Knesek","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Heterotopic ossification (H.O.) is a common occurrence after total hip arthroplasty (THA) with significant potential clinical ramifications. Controversy still exists regarding the exact etiology of the disorder, including possible risk factors. Surgical technique, surgical approach, postoperative medication protocols and even thromboembolic prophylaxis have been implicated in the formation of H.O. Our study looked at one institution with a single surgeon performing direct anterior THA (DAA THA) in patients who received aspirin (ASA) as monotherapy for thromboembolic prophylaxis.</p><p><strong>Methods: </strong>Patients at a single institution who underwent DAA THA between 2015 and 2019 were identified by CPT code. 45 patients ultimately met inclusion criteria. Postoperative radiographs were analyzed retrospectively for H.O. according to the Brooker classification. Several patient characteristics and comorbidities were statistically analyzed using Chi-square tests, Fisher Exact tests, Wilcox rank sum tests, and Pearson correlation.</p><p><strong>Results: </strong>12 patients (26.7%) were found to have heterotopic ossification (67% Class 1, 8% Class 2, 25% Class 3, and 0% Class 4); with a median follow up of 35 weeks (range: 12-96). 25% of these patients received ASA 325mg BID while 75% received ASA 81 BID. No statistical differences in development of H.O. were detected among age, gender, BMI, sex, race, diabetes, or NSAID use in the post-operative interval. There were significantly more smokers in the H.O. group (50% vs. 9%, p<0.006).</p><p><strong>Conclusions: </strong>Our analysis aimed to quantify the incidence of H.O. with consistency in surgical approach and post-operative protocol. There have been few studies on this topic, and we believe it is very relevant with the increasing use of aspirin in the post-operative protocol for thromboembolic prophylaxis. Our retrospective analysis identified H.O. at rates similar to previous studies in DAA.</p>","PeriodicalId":74853,"journal":{"name":"Spartan medical research journal","volume":"5 1","pages":"12263"},"PeriodicalIF":0.0000,"publicationDate":"2020-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746132/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Spartan medical research journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Heterotopic ossification (H.O.) is a common occurrence after total hip arthroplasty (THA) with significant potential clinical ramifications. Controversy still exists regarding the exact etiology of the disorder, including possible risk factors. Surgical technique, surgical approach, postoperative medication protocols and even thromboembolic prophylaxis have been implicated in the formation of H.O. Our study looked at one institution with a single surgeon performing direct anterior THA (DAA THA) in patients who received aspirin (ASA) as monotherapy for thromboembolic prophylaxis.

Methods: Patients at a single institution who underwent DAA THA between 2015 and 2019 were identified by CPT code. 45 patients ultimately met inclusion criteria. Postoperative radiographs were analyzed retrospectively for H.O. according to the Brooker classification. Several patient characteristics and comorbidities were statistically analyzed using Chi-square tests, Fisher Exact tests, Wilcox rank sum tests, and Pearson correlation.

Results: 12 patients (26.7%) were found to have heterotopic ossification (67% Class 1, 8% Class 2, 25% Class 3, and 0% Class 4); with a median follow up of 35 weeks (range: 12-96). 25% of these patients received ASA 325mg BID while 75% received ASA 81 BID. No statistical differences in development of H.O. were detected among age, gender, BMI, sex, race, diabetes, or NSAID use in the post-operative interval. There were significantly more smokers in the H.O. group (50% vs. 9%, p<0.006).

Conclusions: Our analysis aimed to quantify the incidence of H.O. with consistency in surgical approach and post-operative protocol. There have been few studies on this topic, and we believe it is very relevant with the increasing use of aspirin in the post-operative protocol for thromboembolic prophylaxis. Our retrospective analysis identified H.O. at rates similar to previous studies in DAA.

Abstract Image

Abstract Image

Abstract Image

使用阿司匹林预防血栓栓塞的直接前路全髋关节置换术中异位骨化的发生率。
背景:异位骨化(H.O.)是全髋关节置换术(THA)后的常见病,具有重大的潜在临床影响。关于该疾病的确切病因,包括可能的风险因素,目前仍存在争议。手术技术、手术方法、术后用药方案甚至血栓栓塞预防措施都与 H.O 的形成有关。我们的研究考察了一家医疗机构中由一名外科医生进行直接前路 THA(DAA THA)手术的患者,这些患者接受了阿司匹林(ASA)作为血栓栓塞预防的单一疗法:根据 CPT 编码确定了 2015 年至 2019 年期间在一家医疗机构接受 DAA THA 的患者。最终有 45 名患者符合纳入标准。根据 Brooker 分类法对术后 X 光片进行回顾性分析,以确定是否存在 H.O.。使用Chi-square检验、Fisher Exact检验、Wilcox秩和检验和Pearson相关性对几种患者特征和合并症进行了统计分析:12名患者(26.7%)被发现患有异位骨化(67%为1级,8%为2级,25%为3级,0%为4级);中位随访时间为35周(范围:12-96周)。其中 25% 的患者服用 ASA 325 毫克,每日一次;75% 的患者服用 ASA 81 毫克,每日一次。在术后间隔期内,未发现不同年龄、性别、体重指数、性别、种族、糖尿病或使用非甾体抗炎药的患者在发生 H.O.方面存在统计学差异。H.O.组中吸烟者明显较多(50% 对 9%,P结论:我们的分析旨在量化H.O.的发生率,并与手术方法和术后方案保持一致。我们认为,随着阿司匹林在术后血栓栓塞预防方案中的使用越来越多,这个问题非常重要。我们的回顾性分析发现,H.O.的发生率与之前的 DAA 研究相似。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信